Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31617| Title: | The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. | Austin Authors: | Cox, Ingrid A;de Graaff, Barbara;Ahmed, Hasnat;Campbell, Julie;Otahal, Petr;Corte, Tamera J;Moodley, Yuben;Goh, Nicole S L ;Hopkins, Peter;Macansh, Sacha;Walters, E Haydn;Palmer, Andrew J | Affiliation: | Menzies Institute for Medical Research, University of Tasmania Respiratory and Sleep Medicine NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia. Australian Idiopathic Pulmonary Fibrosis Registry, Lung Foundation of Australia, New South Wales, Australia. |
Issue Date: | 27-Oct-2022 | Date: | 2022 | Publication information: | The European Journal of Health Economics : HEPAC 2022 | Abstract: | Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease found mostly in elderly persons, characterized by a high symptom burden and frequent encounters with health services. This study aimed to quantify the economic burden of IPF in Australia with a focus on resource utilization and associated direct costs. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31617 | DOI: | 10.1007/s10198-022-01538-7 | ORCID: | 0000-0001-5130-4088 |
Journal: | The European Journal of Health Economics : HEPAC | PubMed URL: | 36289130 | ISSN: | 1618-7601 | Type: | Journal Article | Subjects: | Cost of illness Economic burden Heath resource utilization Idiopathic pulmonary fibrosis |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.